Proposal for individualized dosing of eculizumab in atypical hemolytic uremic syndrome: patient friendly and cost-effective.
Mendy Ter AvestRomy N BouwmeesterCaroline DuineveldKioa L WijnsmaElena B VolokhinaLambertus P W J van den HeuvelDavid M BurgerJack F M WetzelsNicole C A J van de KarRob Ter Heinenull nullPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
A patient-friendly individualized dosing strategy of eculizumab has the potential to improve treatment response at reduced costs.